戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hrombocytopenic by i.p. administration of an antiplatelet antibody.
2 hrombosis and shock observed with activating antiplatelet antibody.
3 d severe thrombocytopenia than nonactivating antiplatelet antibody.
4 plore the consequences in vivo of activating antiplatelet antibodies.
5  thrombocytopenia mediated by drug-dependent antiplatelet antibodies.
6 esponse to cytotoxic anti-red blood cell and antiplatelet antibodies.
7 hrombosis in patients with heparin-dependent antiplatelet: antibodies.
8 0 to 2 g/kg IVIG and then challenged with an antiplatelet antibody (7E3, 8 mg/kg).
9  peripheral platelet destruction mediated by antiplatelet antibodies (Abs) and/or platelet-bound immu
10 fection, an ovarian teratoma with associated antiplatelet antibodies, and multiple platelet transfusi
11 whether breast milk of ITP mothers contained antiplatelet antibodies causing persistent thrombocytope
12 th previous work, IVIG was found to increase antiplatelet antibody clearance in a dose-dependent mann
13                                      Without antiplatelet antibodies, CRP was found to be inert towar
14 ction in ITP (ie, IVIG-mediated increases in antiplatelet antibody elimination).
15                            Thus, transfer of antiplatelet antibodies from ITP mothers by breastfeedin
16       Flow cytometry was used to demonstrate antiplatelet antibodies in 80% of first serum samples fr
17 ls into plasma cells and to the secretion of antiplatelet antibodies in ITP patients.
18        The detection of vancomycin-dependent antiplatelet antibodies in patients receiving the antibi
19                                              Antiplatelet antibodies may contribute to the profound t
20                 We found increased levels of antiplatelet antibodies of the immunoglobulin A type in
21                                              Antiplatelet-antibody-producing B cells play a key role
22                            Here, we detected antiplatelet antibodies targeting platelet glycoprotein
23 ing bone marrow aspiration, Coombs test, and antiplatelet antibody test were negative.
24  immune thrombocytopenia (ITP) commonly have antiplatelet antibodies that cause thrombocytopenia thro
25 choline exposed after oxidation triggered by antiplatelet antibodies, thereby enhancing platelet phag
26                                The use of an antiplatelet antibody to halve platelet counts in tumor-